iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
企業コードISPC
会社名iSpecimen Inc
上場日Jun 17, 2021
最高経営責任者「CEO」Mr. Robert Bradley Lim
従業員数24
証券種類Ordinary Share
決算期末Jun 17
本社所在地8 Cabot Road
都市WOBURN
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号08101
電話番号17813016700
ウェブサイトhttps://www.ispecimen.com/
企業コードISPC
上場日Jun 17, 2021
最高経営責任者「CEO」Mr. Robert Bradley Lim
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし